Sign in

or Register now

ADHDCentral.com

    See all of our health sites at www.HealthCentral.com
    Wednesday, November 25, 2009
    • Font size
    • Bookmark
    • Save

    FDA approves ADHD med Intuniv

    (Reuters) UPDATED 2009-09-09
    The U.S. Food and Drug Administration has approved the extended-release ADHD drug Intuniv. Intuniv will be the first selective alpha-2A receptor agonist approved for the treatment of ADHD. The drug is approved for children ages 6 to 17, and should be available from pharmacies beginning in November 2009.  Read full story >
    See all ADHD News
    • Font size
    • Bookmark
    • Was this helpful? Yes
    • Save

    People who read this also read...

    Note: All clinical content on this site is physician-reviewed, except material generated by our community members.
    Non-Profit Affiliates:
    • CHADD logo
    • Attention Deficit Disorder of America Logo
    Featuring Content From:
    • Harvard Health Publications
    • A.D.A.M.
    • Thomson PDR
    • Ivanhoe Broadcast News

    By using this service, you accept our Terms of Use. Please read them. The consumer health information on ADHDCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

    This website is accredited by Health On the Net Foundation. Click to verify.We comply with the HONcode standard for trustworthy health information: verify here.
    • TRUSTe Certified Privacy
    • Health Care Standard of Excellence
    • FREDDIE International Health and Medical Media Award Finalist